The chart looks hard to beat on this stock over almost any time period particularly from 5 years ago. Key milestones coming up are whether it gets into the ASX200 in March (or will be June, if not in March) and the FDA PDUFA date of 8 July for Scenesse - which is already approved in Europe and making money. There is also the threat of topical formulations being released by the company although I do not expect this to happen until after July FDA.
What would be of great benefit given the obvious trading accumulation and accompanying scaremongering is an 8horse -style broker analysis over the last 1 month, 3 months & 6 months to get some idea of broker/bot trading patterns. There is also shorter activity where I calculate the shorters are well into loss and any blip (ex ASX200 inclusion) could be exacerbated by short covering.
If 8horse is reading the 3 broker analyses would be greatly appreciated.
Anyone?, page-2
-
- There are more pages in this discussion • 5 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add CUV (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$15.59 |
Change
0.470(3.11%) |
Mkt cap ! $780.7M | |||
| Open | High | Low | Value | Volume |
| $15.12 | $15.99 | $15.12 | $2.345M | 149.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 500 | $15.59 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $15.66 | 92 | 1 |
View Market Depth
| Last trade - 16.10pm 13/09/2024 (20 minute delay) ? |
| CUV (ASX) Chart |